NCT00117988
- Conditions
- Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Anaplastic Large Cell Lymphoma
Explore clinical trials studying Anaplastic Large Cell Lymphoma. Study availability and eligibility vary by location and protocol.
84 public trials
6 recruiting studies
Anaplastic Large Cell Lymphoma trial results
Completed
Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
NCT00058019
- Conditions
- Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +25 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT00606645
- Conditions
- Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
- Locations
-
- Rush University Medical Center Chicago, Illinois, United States
- Ohio State University Columbus, Ohio, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- MD Anderson Cancer Center Houston, Texas, United States
Completed
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
NCT00890747
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
- Northwestern University Chicago, Illinois, United States
- AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
NCT00499811
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- National Institutes of Health Bethesda, Maryland, United States
NCT00458731
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +116 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00769288
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +107 more
- Locations
-
- Wayne State University Detroit, Michigan, United States
Completed
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
NCT01129180
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +35 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00293345
- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +107 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00348985
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +109 more
- Locations
-
- University of Colorado Denver, Colorado, United States